Cell Death Discovery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2024-10-24 ms1000001788822126 来自北京

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：医学
经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。

33 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-03-12 ms1000001490330585 来自广东省

别投，久到让人头皮发麻

9 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-03-31 ms6000000281231332 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：生物学现象
经验分享：Decision sent to Author 26th Mar 25 10:14:33
Decision Sent to Author 26th Mar 25 10:14:33
Decision Made 26th Mar 25 10:13:40
Manuscript Under Consideration 26th Mar 25 10:12:57
Editor Assigned 17th Mar 25 22:27:21
Manuscript Received 17th Mar 25 22:27:03
Revision Received 17th Mar 25 22:07:20
Waiting for Revision 17th Mar 25 12:43:44
Decision Sent to Author 17th Mar 25 12:43:44
Decision Made 17th Mar 25 05:07:05
Manuscript Under Consideration 13th Mar 25 01:19:43
13th Mar 25 01:19:43
Manuscript Under Consideration 12th Mar 25 11:02:03
Editor Assigned 11th Mar 25 03:30:01
Manuscript Received 11th Mar 25 03:30:00
Revision Received 25th Feb 25 00:42:41
Waiting for Revision 24th Feb 25 09:45:11
Decision Sent to Author 24th Feb 25 09:45:11
Decision Made 24th Feb 25 06:50:19
Manuscript Under Consideration 18th Feb 25 04:26:34
18th Feb 25 04:26:34
Manuscript Under Consideration 8th Jan 25 10:48:18
Editor Assigned 7th Jan 25 22:47:21
Manuscript Received 7th Jan 25 22:47:20

8 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-02-20 ms6000002098058965 来自湖北省

请问大家最近投稿UC需要多长时间做决定呀

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-02-08 智慧无穷来自安徽省

偏重的研究方向：医学;免疫;生信
经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2024-12-31 xgwan123 来自辽宁省

审稿速度:2.0
经验分享：under consideration 50天

23 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-02-16 xgwan123 来自辽宁省

审稿速度:3.0
经验分享：under consideration100天

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-02-16 xgwan123 来自辽宁省

审稿速度:6.0
经验分享：under consideration100

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2023-12-01 ms2000000658865901 来自广东省

偏重的研究方向：机制
经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久

80 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2232962, encodeId=4eb32232962d5, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：医学 经验分享：投稿后一个多月才找到审稿人，反复修回两次，最后接收录用。难度不高，但是效率有点慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822126, createdTime=Thu Oct 24 23:40:52 CST 2024, time=2024-10-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2255696, encodeId=49302255696cb, content=别投，久到让人头皮发麻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Wed Mar 12 01:54:46 CST 2025, time=2025-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2258534, encodeId=04b12258534a3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：生物学现象 经验分享：Decision sent to Author 26th Mar 25 10:14:33 Decision Sent to Author 26th Mar 25 10:14:33 Decision Made 26th Mar 25 10:13:40 Manuscript Under Consideration 26th Mar 25 10:12:57 Editor Assigned 17th Mar 25 22:27:21 Manuscript Received 17th Mar 25 22:27:03 Revision Received 17th Mar 25 22:07:20 Waiting for Revision 17th Mar 25 12:43:44 Decision Sent to Author 17th Mar 25 12:43:44 Decision Made 17th Mar 25 05:07:05 Manuscript Under Consideration 13th Mar 25 01:19:43 13th Mar 25 01:19:43 Manuscript Under Consideration 12th Mar 25 11:02:03 Editor Assigned 11th Mar 25 03:30:01 Manuscript Received 11th Mar 25 03:30:00 Revision Received 25th Feb 25 00:42:41 Waiting for Revision 24th Feb 25 09:45:11 Decision Sent to Author 24th Feb 25 09:45:11 Decision Made 24th Feb 25 06:50:19 Manuscript Under Consideration 18th Feb 25 04:26:34 18th Feb 25 04:26:34 Manuscript Under Consideration 8th Jan 25 10:48:18 Editor Assigned 7th Jan 25 22:47:21 Manuscript Received 7th Jan 25 22:47:20, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6af5572983, createdName=ms6000000281231332, createdTime=Mon Mar 31 16:20:52 CST 2025, time=2025-03-31, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252762, encodeId=da4a2252e62bf, content=请问大家最近投稿UC需要多长时间做决定呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea259213833, createdName=ms6000002098058965, createdTime=Thu Feb 20 10:14:10 CST 2025, time=2025-02-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2251054, encodeId=0a072251054b4, content=偏重的研究方向：医学;免疫;生信 经验分享：刚刚投稿了，加油🙏🏻不知道这个期刊怎么样，大佬们审稿人意见中肯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4c26582112, createdName=智慧无穷, createdTime=Sat Feb 08 17:40:29 CST 2025, time=2025-02-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2245972, encodeId=52ee22459e227, content=审稿速度:2.0 经验分享：under consideration 50天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Tue Dec 31 19:26:29 CST 2024, time=2024-12-31, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252193, encodeId=ae8f22521935b, content=审稿速度:3.0 经验分享：under consideration100天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:35:55 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2252195, encodeId=d535225219515, content=审稿速度:6.0 经验分享：under consideration100, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Sun Feb 16 15:39:48 CST 2025, time=2025-02-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2172280, encodeId=5e3221e2280fe, content=偏重的研究方向：机制 经验分享：Decision Made25th Nov 23 Manuscript Under Consideration13th Nov 23 Editor Assigned10th Nov 23 Manuscript Received10th Nov 23 等待的好焦急，要拒就快点拒，不知道要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dab08614153, createdName=ms2000000658865901, createdTime=Fri Dec 01 10:05:16 CST 2023, time=2023-12-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2251447, encodeId=3d5a225144e6e, content=审稿速度:24.0 经验分享：审稿很慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c159067710, createdName=ms4000001559903834, createdTime=Tue Feb 11 13:29:18 CST 2025, time=2025-02-11, status=1, ipAttribution=北京)]

2025-02-11 ms4000001559903834 来自北京

审稿速度:24.0
经验分享：审稿很慢

13 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务